Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Svetlana B. McKee"'
Autor:
Timothy G. Norwood, Carrie A. Lenneman, MD, Brian C. Westbrook, Silvio H. Litovsky, MD, Svetlana B. McKee, RN, BSN, Robert M. Conry, MD
Publikováno v:
JACC: Case Reports, Vol 2, Iss 2, Pp 203-209 (2020)
Ipilimumab and nivolumab for melanoma induced smoldering myocarditis remitting with steroids. Rechallenge with nivolumab produced steroid-refractory myocarditis confirmed by electron microscopy. Tacrolimus and mycophenolate transiently reduced inflam
Externí odkaz:
https://doaj.org/article/5defb6f3435e4bbeb14a04c093d865bb
Autor:
Timothy G. Norwood, Brian C. Westbrook, Douglas B. Johnson, Silvio H. Litovsky, Nina L. Terry, Svetlana B. McKee, Alan S. Gertler, Javid J. Moslehi, Robert M. Conry
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-6 (2017)
Abstract Background Severe myocarditis associated with electrical conduction abnormalities and occasionally heart failure has been well documented following treatment with immune checkpoint blockade with an estimated incidence of less than 1%. Howeve
Externí odkaz:
https://doaj.org/article/954f4ac729624cc49ee9c4c13eb10484
Autor:
Jonathan T. Blackmon, Michael S. Stratton, MD, Young Kwak, MD, Peter G. Pavlidakey, MD, Andrzej T. Slominski, MD, Svetlana B. McKee, RN, BSN, Toni M. Viator, RN, Ju Young Kim, PhD, Conway C. Huang, MD, Robert M. Conry, MD
Publikováno v:
JAAD Case Reports, Vol 3, Iss 4, Pp 280-283 (2017)
Externí odkaz:
https://doaj.org/article/9c7d8758102c4169a6e9450ef66bd8d3
Autor:
Robert M. Conry, Timothy G. Norwood, Carrie Lenneman, Silvio H. Litovsky, Brian C. Westbrook, RN Svetlana B. McKee
Publikováno v:
JACC: Case Reports, Vol 2, Iss 2, Pp 203-209 (2020)
Ipilimumab and nivolumab for melanoma induced smoldering myocarditis remitting with steroids. Rechallenge with nivolumab produced steroid-refractory myocarditis confirmed by electron microscopy. Tacrolimus and mycophenolate transiently reduced inflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33bc43839b6caf4430eedbd392733a5a
https://doi.org/10.1016/j.jaccas.2019.11.076
https://doi.org/10.1016/j.jaccas.2019.11.076
Publikováno v:
JAAD Case Reports
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43307cc7d79ed54f453d0e4c99fd2f4
https://doi.org/10.1016/j.jdcr.2019.06.034
https://doi.org/10.1016/j.jdcr.2019.06.034
Autor:
Douglas B. Johnson, Svetlana B. McKee, Fei Ye, Debbie E. Wallace, Alice Zhou, Daniel Y. Wang, Robert M. Conry, Kristin K. Ancell, Chun‐Che Wen
Publikováno v:
J Surg Oncol
BACKGROUND AND OBJECTIVES Patients with in-transit or limited cutaneous metastatic melanoma may benefit from intralesional injections with talimogene laherparepvec (TVEC), a modified oncolytic herpesvirus. However, its use in patients with adverse pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a709869d0c1a0f942a9f283f4d6e2c
https://doi.org/10.1002/jso.25601
https://doi.org/10.1002/jso.25601
Publikováno v:
Human Vaccines & Immunotherapeutics
Oncolytic viruses represent a novel drug class in which native or modified viruses mediate tumor regression through selective replication within and lysis of tumor cells as well as induction of systemic antitumor immunity capable of eradicating tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eaceb3065ff93be0900281d3d114048
https://doi.org/10.1080/21645515.2017.1412896
https://doi.org/10.1080/21645515.2017.1412896
Autor:
Nina L.J. Terry, Javid Moslehi, Silvio H. Litovsky, Alan S. Gertler, Brian C. Westbrook, Robert M. Conry, Timothy G. Norwood, Douglas B. Johnson, Svetlana B. McKee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-6 (2017)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background Severe myocarditis associated with electrical conduction abnormalities and occasionally heart failure has been well documented following treatment with immune checkpoint blockade with an estimated incidence of less than 1%. However, the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4005146909218be837eb961440bf161
http://link.springer.com/article/10.1186/s40425-017-0296-4
http://link.springer.com/article/10.1186/s40425-017-0296-4
Autor:
Ju Y. Kim, Howard L. Kaufman, Svetlana B. McKee, Robert M. Conry, Ashlyn S. Everett, Peter G. Pavlidakey, Jennifer F. De Los Santos, Carlo M. Contreras
Publikováno v:
Journal of Cutaneous Pathology. 45:48-53
Talimogene laherparepvec (TVEC) is the first oncolytic viral immunotherapy approved by the FDA, for advanced melanoma consisting of genetically modified herpes simplex type 1 virus which selectively replicates causing tumor lysis, expressing granuloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b07ed882419780905486a868dbc01d60
https://doi.org/10.1111/cup.13048
https://doi.org/10.1111/cup.13048
Autor:
Young Kwak, Jonathan T. Blackmon, Michael Slade Stratton, Conway C. Huang, Toni M. Viator, Robert M. Conry, Peter G. Pavlidakey, Andrzej Slominski, Ju Young Kim, Svetlana B. McKee
Publikováno v:
JAAD Case Reports, Vol 3, Iss 4, Pp 280-283 (2017)
JAAD Case Reports
JAAD Case Reports
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d426eefb11a6ebdbecdef0fae64a37
https://doi.org/10.1016/j.jdcr.2017.02.011
https://doi.org/10.1016/j.jdcr.2017.02.011